With the FDA granting a priority review to the BLA, a decision from the regulatory body is expected on July 22, 2025. Shares of REPL were up 16.9% on Jan. 21 following the announcement of the news ...

Reports of unsolicited real estate offers are targeting older homeowners and putting their financial well-being and housing ...

Shares of NASDAQ REPL opened at $12.29 on Thursday. The firm’s 50-day moving average is $12.78 and its two-hundred day moving average is $12.04. The company has a market capitalization of $946. ...

WOBURN, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...

Founded in 2015, REPL Sports is a leading sports organisation dedicated to promoting healthier lifestyles among today’s youth ...

Shares of REPL stock opened at $14.10 on Thursday. The company has a market cap of $964.72 million, a price-to-earnings ratio of -4.62 and a beta of 1.30. Replimune Group has a 52 week low of $4. ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Reports of unsolicited real estate offers targeting older homeowners have surged in some parts of Ohio, potentially putting these individuals’ financial well-being and housing security at risk and ...